This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Parasitic Diseases or Bacterial Diseases
and you are
between 5 and 65
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study is to determine whether the triple co administration of albendazole, ivermectin and azithromycine is as safe as the current treatment scheme that consists to treat with albendazole plus ivermectin together and a week later to treat with azithromycin in areas co endemic for lymphatic filariasis and trachoma.

Provided treatments

  • Drug: triple co administration at once of the combination of Albendazole + ivermectin + azithromycin

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01586169. The sponsor of the trial is Centre d'Appui à la lutte contre la Maladie and it is looking for 3000 volunteers for the current phase.
Official trial title:
A Pharmacovigilance Study on the Safety of Integrated Treatment of Trachoma and Lymphatic Filariasis in Children and Adults Living in the Sikasso Region of Mali